Atai Beckley N V (ATAI)

Dec 23, 2025

Jones Trading Initiates Coverage of Atai Beckley N.V. (ATAI) with Buy Recommendation - Nasdaq

Dec 23, 2025

Dec 23, 2025

JonesTrading Initiates Coverage on ATAI Life Sciences With Buy Rating, $16 Price Target - marketscreener.com

Dec 23, 2025

Dec 23, 2025

Jones Trading initiates Buy rating on atai Life Sciences stock with $16 target - Investing.com

Dec 23, 2025

Dec 23, 2025

AtaiBeckley joins the Nasdaq Biotechnology Index - Proactive financial news

Dec 23, 2025

Dec 23, 2025

Atai Beckley Added to Nasdaq Biotechnology Index - marketscreener.com

Dec 23, 2025

Dec 23, 2025

Atai Beckley N.V. Added to NASDAQ Biotechnology Index, Marking a Significant Milestone for the Company - Quiver Quantitative

Dec 23, 2025

Dec 23, 2025

AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI) - The Manila Times

Dec 23, 2025

Dec 22, 2025

MarketBeat's Top 5 Rated Small-Cap Stocks - Finviz

Dec 22, 2025

Dec 22, 2025

Atai Beckley N.V.(NasdaqGM: ATAI) added to NASDAQ Biotechnology Index - marketscreener.com

Dec 22, 2025

Dec 21, 2025

Psychedelics stocks could benefit from marijuana rescheduling: Jefferies - MSN

Dec 21, 2025

Dec 19, 2025

How Does Atai (ATAI)’s New EMP-01 Patent Shape Its Psychedelic Therapy Moat? - simplywall.st

Dec 19, 2025

Dec 18, 2025

Atai Life Sciences N.V. (ATAI) Secures Patent for Social Anxiety Disorder Formulation - Insider Monkey

Dec 18, 2025

Dec 16, 2025

CapEx per share of Atai Beckley N.V – LSX:A3CSB4 - TradingView — Track All Markets

Dec 16, 2025

Dec 11, 2025

New EMP-01 Patent Win Could Be A Game Changer For Atai Beckley (ATAI) - simplywall.st

Dec 11, 2025

Dec 11, 2025

ATAI Beckley Secures US Patent for EMP-01 to Treat Social Anxiety Disorder; Shares Up Pre-Bell - marketscreener.com

Dec 11, 2025

Dec 11, 2025

AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio - The Manila Times

Dec 11, 2025

Dec 11, 2025

AtaiBeckley (NASDAQ: ATAI) gains EMP-01 patent, eyes Phase 2a data in 2026 - Stock Titan

Dec 11, 2025

Dec 05, 2025

Atai Beckley files prospectus supplement for registered shares after Beckley Psytech acquisition - Investing.com Australia

Dec 05, 2025

Dec 05, 2025

Atai Beckley files prospectus supplement for registered shares after Beckley Psytech acquisition By Investing.com - Investing.com South Africa

Dec 05, 2025

Dec 05, 2025

ATAI Life Sciences Files Prospectus for Share Registration - TipRanks

Dec 05, 2025

Dec 05, 2025

Atai Beckley N.V. Files Prospectus Supplement for Common Shares - TradingView — Track All Markets

Dec 05, 2025

Dec 03, 2025

Atai Life Sciences (ATAI): Assessing an 8.8x Price-to-Book Valuation After a Volatile Share Price Run - Yahoo Finance

Dec 03, 2025

Dec 01, 2025

Atai Beckley (ATAI) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 01, 2025

Nov 28, 2025

ATAIAtai Beckley N.V Short Interest - Finviz

Nov 28, 2025

Nov 28, 2025

ATAI Life Sciences Files Prospectus for Share Resale - MSN

Nov 28, 2025

Nov 27, 2025

atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates - ADVFN

Nov 27, 2025

Nov 27, 2025

Form 8-KCurrent report - ADVFN

Nov 27, 2025

Nov 27, 2025

AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - ADVFN

Nov 27, 2025

Nov 26, 2025

[Form 4] Atai Beckley N.V. Insider Trading Activity - Stock Titan

Nov 26, 2025

Nov 26, 2025

H.C. Wainwright Maintains Buy on Atai Beckley (ATAI) Following Breakthrough Therapy and Merger Completion - MSN

Nov 26, 2025

Nov 25, 2025

Atai Beckley N.V. (ATAI) latest stock news and headlines - Yahoo Finance UK

Nov 25, 2025

Nov 24, 2025

AtaiBeckley advances BPL-003 toward Phase 3 After Strong Phase 2 Data topline data i - Proactive financial news

Nov 24, 2025

Nov 23, 2025

9 Oversold Biotech Stocks to Invest In - Insider Monkey

Nov 23, 2025

Nov 22, 2025

Atai Beckley NV (NASDAQ:ATAI)Shares, Dividends & News - intelligentinvestor.com.au

Nov 22, 2025

Nov 19, 2025

Enhanced (ATAI) overhauls leadership, appoints new CEO, executive chairman and CFO - Stock Titan

Nov 19, 2025

Nov 18, 2025

Atai Beckley N.V. (ATAI) Receives Buy Rating on BPL-003 Edge against Spravato - MSN

Nov 18, 2025

Nov 16, 2025

Atai Beckley N.V (ATAI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 16, 2025

Nov 14, 2025

H.C. Wainwright reiterates Buy rating on atai Life Sciences stock By Investing.com - Investing.com Nigeria

Nov 14, 2025

Nov 14, 2025

H.C. Wainwright reiterates Buy rating on atai Life Sciences stock - Investing.com India

Nov 14, 2025

Nov 13, 2025

AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London - The Manila Times

Nov 13, 2025

Nov 13, 2025

AtaiBeckley (NASDAQ: ATAI) London fireside chat at 11:30 GMT; replay for 90 days - Stock Titan

Nov 13, 2025

Nov 12, 2025

AtaiBeckley advances clinical pipeline, strengthens balance sheet in Q3 - Proactive financial news

Nov 12, 2025

Nov 12, 2025

Atai Beckley Q3 Loss Widens, Revenue Rises; Shares Down Pre-Bell - MarketScreener

Nov 12, 2025

Nov 12, 2025

[8-K] ATAI Life Sciences N.V. Reports Material Event | ATAI SEC FilingForm 8-K - Stock Titan

Nov 12, 2025

Nov 12, 2025

Atai Beckley N.V. Announces Breakthrough Therapy Designation for BPL-003 and Positive Phase 2 Results for Treatment-Resistant Depression - Quiver Quantitative

Nov 12, 2025

Nov 12, 2025

Earnings Flash (ATAI) Atai Beckley N.V. Reports Q3 Revenue $749,000 - MarketScreener

Nov 12, 2025

Nov 12, 2025

Earnings Flash (ATAI) Atai Beckley Posts Q3 Net Loss $0.28 a Share, vs. FactSet Est of $0.11 Loss - MarketScreener

Nov 12, 2025

Nov 12, 2025

AtaiBeckley (NASDAQ: ATAI) closes approx. $150M offering, funding into 2029 - Stock Titan

Nov 12, 2025